Frequentist andBayesian meta‐regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient data-Reference-Cited by-同舟云学术

Frequentist andBayesian meta‐regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient data

Published:2019-02-20 Issue:5 Volume:28 Page:653-665
ISSN:1057-9230
Container-title:Health Economics
language:en
Short-container-title:Health Economics

Author:

Hatswell Anthony J.¹²^ORCID,Burns Darren³,Baio Gianluca¹^ORCID,Wadelin Frances⁴

Affiliation:

1. Department of Statistical ScienceUniversity College London London UK

2. Delta Hat LimitedUniversity Nottingham University Hospital Nottingham UK

3. BresMedUniversity Nottingham University Hospital Sheffield UK

4. Nottingham University Hospital Nottingham UK

Funder

Janssen Pharmaceuticals

Publisher

Wiley

Subject

Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hec.3871

Reference35 articles.

1. Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey

2. Estimating Eortc-8d Health State Utility Values From Eortc Qlq-C30 Scores In Relapsed Multiple Myeloma

3. Mapping Utility Scores from European organization for Treatment of Cancer Core-30 Questionnaire Scores (Eortc Qlq-C30) In Relapsed Multiple Myeloma

4. The number of subjects per variable required in linear regression analyses

5. Canty A. &Ripley B.(2016).boot: Bootstrap R (S‐Plus) Functions. R Package Version 1.3–18.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone Marrow Biopsies: Is CT, Fluoroscopy, or no Imaging Guidance the Most Cost-Effective Strategy?;Academic Radiology;2024-07

2. Bayesian Meta-Analysis of Health State Utility Values: A Tutorial with a Practical Application in Heart Failure;PharmacoEconomics;2024-05-20

3. Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations;PharmacoEconomics;2024-03-29

4. Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma;Transplantation and Cellular Therapy;2024-01

5. Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power Prior;Value in Health;2023-09